Literature DB >> 15996630

The changing pattern of hepatitis B virus infection over the past three decades in Italy.

T Stroffolini1.   

Abstract

By the end of 1970s, Italy was a country at medium endemic level of hepatitis B virus infection, with wide geographical differences; intrafamily transmission was the major mode by which infection spread; hepatitis B e antigen positivity and hepatitis Delta positivity were frequently detected in hepatitis B surface antigen chronic carriers; a high proportion of subjects with chronic liver disease resulted as hepatitis B surface antigen positive. Three decades apart, the picture was completely changed, as documented by several surveys. Nowadays, Italy is a country at very low endemic level of hepatitis B, without geographical differences; the infection is mostly sexually transmitted; hepatitis B e antigen positivity and hepatitis Delta positivity are rarely detected in hepatitis B surfaces antigen chronic carriers; a low proportion of subjects with chronic liver disease result hepatitis B surface antigen positive. These important changes may be due to both non-specific (i.e. improvement in socio-demographic features) and specific (i.e. a comprehensive vaccination program against hepatitis B) preventive measures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996630     DOI: 10.1016/j.dld.2005.02.010

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  14 in total

1.  Epidemiology of hepatitis D virus (HDV) infection in an urban area of northern Italy.

Authors:  M De Paschale; M T Manco; L Belvisi; C Magnani; T Re; P Viganò; S Biagiotti; F Capelli; A Mazzone; M P Baldacci; A Ferrara; A L Neri; C M Guastoni; R A Bonazzina; B Brando; P Clerici
Journal:  Infection       Date:  2012-02-25       Impact factor: 3.553

2.  Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits.

Authors:  Sara Boccalini; Cristina Taddei; Vega Ceccherini; Angela Bechini; Miriam Levi; Dario Bartolozzi; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2013-02-01       Impact factor: 3.452

3.  Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy.

Authors:  Evangelista Sagnelli; Tommaso Stroffolini; Caterina Sagnelli; Mario Pirisi; Sergio Babudieri; Guido Colloredo; Maurizio Russello; Nicola Coppola; Giovanni Battista Gaeta; Bruno Cacopardo; Massimo De Luca; Piero Luigi Almasio
Journal:  Infection       Date:  2017-11-17       Impact factor: 3.553

4.  Hepatitis delta infection in Italian patients: towards the end of the story?

Authors:  Tommaso Stroffolini; Evangelista Sagnelli; Caterina Sagnelli; Maurizio Russello; Massimo De Luca; Floriano Rosina; Bruno Cacopardo; Giuseppina Brancaccio; Caterina Furlan; Giovanni Battista Gaeta; Anna Licata; Piero Luigi Almasio
Journal:  Infection       Date:  2016-11-05       Impact factor: 3.553

5.  Prevalence of markers of hepatitis B virus infection or vaccination in HBsAg-negative subjects.

Authors:  Massimo De Paschale; Maria Teresa Manco; Luisa Belvisi; Bruno Brando; Stefania Latella; Carlo Agrappi; Paola Mirri; Arianna Gatti; Pierangelo Clerici
Journal:  Blood Transfus       Date:  2012-04-13       Impact factor: 3.443

6.  Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study.

Authors:  M Fasano; A Saracino; G Carosi; F Mazzotta; N Marino; E Sagnelli; G B Gaeta; G Angarano; G Verucchi; P Bellissima; C Angeletti; T Santantonio
Journal:  Infection       Date:  2012-12-21       Impact factor: 3.553

Review 7.  Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Mariantonietta Pisaturo; Margherita Macera; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

8.  Impact of universal vaccination against hepatitis B: the italian model.

Authors:  Rosa Cristina Coppola; Angelo Meloni; Marcello Campagna
Journal:  Hepat Mon       Date:  2012-07-30       Impact factor: 0.660

9.  An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy.

Authors:  Giuseppe La Torre; Nicola Nicolotti; Chiara de Waure; Giacomina Chiaradia; Maria Lucia Specchia; Alice Mannocci; Walter Ricciardi
Journal:  Virol J       Date:  2008-07-24       Impact factor: 4.099

10.  Effectiveness of DNA-recombinant anti-hepatitis B vaccines in blood donors: a cohort study.

Authors:  Emil Kupek; Denise E R de Souza; Andrea Petry
Journal:  BMC Infect Dis       Date:  2007-11-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.